Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Leena Gandhi is the Director of the Center for Cancer Therapeutic Innovation at the Dana-Farber Cancer Institute. She received her PhD from the University of California, Berkeley in 1998 and her MD from New York University in 2002. She completed her postgraduate training at Massachusetts General Hospital and at Dana-Farber Cancer Institute in Boston. Dr. Gandhi is a highly accomplished clinical investigator who was a clinical fellow and faculty member at Dana-Farber. She has served as the Director of Thoracic Medical Oncology at New York University and as Vice President of Immuno-Oncology Development at Eli Lilly before returning to Dana-Farber in 2020.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions